Metropolitan Life Insurance Co NY Reduces Holdings in iRobot Co. (NASDAQ:IRBT)

Metropolitan Life Insurance Co NY lessened its stake in shares of iRobot Co. (NASDAQ:IRBT) by 1.9% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 8,619 shares of the industrial products company’s stock after selling 164 shares during the period. Metropolitan Life Insurance Co NY’s holdings in iRobot were worth $1,014,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Osborn Williams & Donohoe LLC purchased a new position in iRobot during the 1st quarter valued at $29,000. Bruderman Asset Management LLC purchased a new position in iRobot during the 4th quarter valued at $58,000. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA grew its position in shares of iRobot by 16.7% in the 1st quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 700 shares of the industrial products company’s stock worth $82,000 after buying an additional 100 shares during the period. American Research & Management Co. purchased a new stake in shares of iRobot in the 1st quarter worth about $118,000. Finally, Bank of Montreal Can grew its position in shares of iRobot by 25.2% in the 4th quarter. Bank of Montreal Can now owns 1,852 shares of the industrial products company’s stock worth $155,000 after buying an additional 373 shares during the period. Institutional investors and hedge funds own 97.16% of the company’s stock.

A number of analysts have recently weighed in on IRBT shares. Zacks Investment Research downgraded shares of Hancock Jaffe Laboratories from a “buy” rating to a “hold” rating in a research report on Wednesday, June 26th. JPMorgan Chase & Co. set a €8.75 ($10.17) target price on shares of Commerzbank and gave the stock a “buy” rating in a research report on Thursday, April 18th. Northland Securities reiterated a “buy” rating and issued a $130.00 price target on shares of iRobot in a research note on Wednesday. Citigroup set a $95.00 price target on shares of iRobot and gave the stock a “hold” rating in a research note on Wednesday, July 3rd. Finally, ValuEngine cut shares of Zosano Pharma from a “buy” rating to a “hold” rating in a research note on Wednesday, May 1st. One analyst has rated the stock with a sell rating, eight have issued a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $109.36.

IRBT traded down $1.95 during midday trading on Thursday, hitting $91.63. 623,184 shares of the company traded hands, compared to its average volume of 772,837. The firm has a 50-day moving average of $90.20. iRobot Co. has a 52 week low of $70.86 and a 52 week high of $132.88. The company has a quick ratio of 1.97, a current ratio of 3.22 and a debt-to-equity ratio of 0.11. The firm has a market cap of $2.57 billion, a price-to-earnings ratio of 21.02, a PEG ratio of 1.43 and a beta of 1.61.

iRobot (NASDAQ:IRBT) last issued its quarterly earnings data on Tuesday, April 23rd. The industrial products company reported $0.84 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.68 by $0.16. iRobot had a net margin of 8.09% and a return on equity of 17.64%. The firm had revenue of $237.66 million for the quarter, compared to analysts’ expectations of $251.40 million. During the same quarter in the prior year, the business earned $0.71 EPS. The business’s quarterly revenue was up 9.5% on a year-over-year basis. On average, analysts expect that iRobot Co. will post 3.13 EPS for the current year.

In related news, CEO Colin M. Angle sold 11,486 shares of the firm’s stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $87.07, for a total value of $1,000,086.02. Following the completion of the sale, the chief executive officer now directly owns 402,368 shares in the company, valued at $35,034,181.76. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Russell J. Campanello sold 11,159 shares of iRobot stock in a transaction on Thursday, June 20th. The stock was sold at an average price of $95.00, for a total value of $1,060,105.00. Following the sale, the executive vice president now owns 28,791 shares of the company’s stock, valued at $2,735,145. The disclosure for this sale can be found here. Insiders sold a total of 23,693 shares of company stock valued at $2,156,268 over the last three months. 3.01% of the stock is currently owned by insiders.

iRobot Company Profile

iRobot Corporation designs, builds, and sells robots for the consumer market worldwide. It offers Roomba floor vacuuming robots; Braava family of automatic floor mopping robots; and Mirra Pool Cleaning Robot to clean residential pools and removes debris as small as two microns from pool floors, walls, and stairs.

Featured Article: What does a bar chart mean for investors?

Institutional Ownership by Quarter for iRobot (NASDAQ:IRBT)

Receive News & Ratings for iRobot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRobot and related companies with MarketBeat.com's FREE daily email newsletter.